|Articles|August 9, 2019
Requirements for Fully Integrated Service Offerings in a HPAPI and Cytotoxic Environment
Author(s)Lonza
• Advantages of using an integrated-service provider • Case study: HPAPI monoplant
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Six New and Nine Indication Extension Recommendations from EMA’s CHMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Women in STEM: Inspiration from Innovators in Pharma
4
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
5